Intra-Cellular Ther (ITCI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ITCI | JAZZ | ASND | ||
| Company | Intra-Cellular Ther | Jazz Pharma Plc | Ascendis Pharma ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 131.90 | 230.87 | 223.49 | ||
| High | 131.98 | 231.78 | 229.31 | ||
| Low | 131.63 | 225.55 | 222.70 | ||
| Latest | 131.87 | 226.77 | 229.07 | ||
| Change | -0.05 | -3.82 | +5.78 | ||
| % Change | -0.04% | -1.66% | +2.59% | ||
| Volume | 16,062,900 | 202,862 | 260,565 | ||
| 20-Day Average Volume | 2,474,570 | 872,866 | 554,922 | ||
| Previous Close | 131.92 | 230.59 | 223.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 131.51 | 234.35 | 225.29 | ||
| 20-Day Raw Stochastic | 86.25% | 19.80% | 52.79% | ||
| 20-Day Relative Strength | 82.75 | 53.14 | 50.83 | ||
| Weighted Alpha | +83.21 | +101.52 | +24.60 | ||
| Today's Opinion | 100% Buy | 88% Buy | 24% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 8% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.13% since 03/25/25 | -0.51% since 06/09/26 | +7.01% since 06/09/26 | ||
| Low | 131.63 on 04/01/25 | 226.12 on 06/10/26 | 208.00 on 06/11/26 | ||
| High | 131.98 on 04/01/25 | 236.71 on 06/11/26 | 228.86 on 06/16/26 | ||
| 1-Month | |||||
| %Chg | +2.86% since 02/28/25 | -0.33% since 05/15/26 | -5.13% since 05/15/26 | ||
| Low | 131.18 on 03/05/25 | 224.23 on 06/02/26 | 203.80 on 06/08/26 | ||
| High | 131.98 on 04/01/25 | 243.32 on 05/22/26 | 249.96 on 05/22/26 | ||
| 3-Month | |||||
| %Chg | +57.89% since 12/31/24 | +25.27% since 03/16/26 | -1.24% since 03/16/26 | ||
| Low | 80.82 on 01/07/25 | 178.32 on 03/18/26 | 203.80 on 06/08/26 | ||
| High | 131.98 on 04/01/25 | 243.32 on 05/22/26 | 250.74 on 04/13/26 | ||
| 6-Month | |||||
| %Chg | +81.51% since 10/01/24 | +34.34% since 12/16/25 | +7.57% since 12/16/25 | ||
| Low | 70.90 on 10/07/24 | 156.95 on 01/08/26 | 188.08 on 01/12/26 | ||
| High | 131.98 on 04/01/25 | 243.32 on 05/22/26 | 250.74 on 04/13/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 14,047,056 | 14,485,202 | 13,928,158 | ||
| Shares Outstanding, K | 106,522 | 62,818 | 62,377 | ||
| Annual Sales | 680,850,000 | 4,267,590,000 | 814,760,000 | ||
| Annual Net Income | -74,680,000 | -356,150,000 | -258,000,000 | ||
| Last Quarter Sales | 199,220,000 | 1,068,900,000 | 288,620,000 | ||
| Last Quarter Net Income | -16,890,000 | 293,100,000 | 736,580,000 | ||
| 60-Month Beta | 0.46 | 0.32 | 0.39 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.16 on 02/21/25 | 6.34 on 05/05/26 | 0.32 on 05/07/26 | ||
| Earnings Date | 05/06/25 | 08/04/26 | 08/06/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 25.23 | 0.00 | ||